Osimertinib
astrazeneca
[]
adura os outcome is positive in case the 'final analysis' and plenary positioning didn't clue you in at #asco23. 
Medical oncologist | Cancer researcher | Somatic cancer genetics | Treatment Biomarkers | Rare Cancers | Melanoma and Skin